Literature DB >> 15041103

Optimising the medical management of benign prostatic hyperplasia.

Michael Marberger1, Richard Harkaway, Jean de la Rosette.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15041103     DOI： 10.1016/j.eururo.2003.10.016

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  9 in total

1.  2010 Update: Guidelines for the management of benign prostatic hyperplasia.

Authors:  J Curtis Nickel; Carlos E Méndez-Probst; Thomas F Whelan; Ryan F Paterson; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2010-10       Impact factor: 1.862

2.  Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 update.

Authors:  J Curtis Nickel; Lorne Aaron; Jack Barkin; Dean Elterman; Mahmoud Nachabé; Kevin C Zorn
Journal:  Can Urol Assoc J       Date:  2018-10       Impact factor: 1.862

3.  Lower urinary tract symptoms in a 66-year-old man.

Authors:  Dean S Elterman; Steven A Kaplan
Journal:  CMAJ       Date:  2014-01-27       Impact factor: 8.262

4.  Association between components of metabolic syndrome and prostatic enlargement: An Indian perspective.

Authors:  P R Nandy; Sabyasachi Saha
Journal:  Med J Armed Forces India       Date:  2016-09-05

5.  Metabolic factors associated with benign prostatic hyperplasia.

Authors:  J Kellogg Parsons; H Ballentine Carter; Alan W Partin; B Gwen Windham; E Jeffrey Metter; Luigi Ferrucci; Patricia Landis; Elizabeth A Platz
Journal:  J Clin Endocrinol Metab       Date:  2006-04-11       Impact factor: 5.958

6.  UPDATE - Canadian Urological Association guideline: Male lower urinary tract symptoms/benign prostatic hyperplasia.

Authors:  Dean Elterman; Mélanie Aubé-Peterkin; Howard Evans; Hazem Elmansy; Malek Meskawi; Kevin C Zorn; Naeem Bhojani
Journal:  Can Urol Assoc J       Date:  2022-08       Impact factor: 2.052

Review 7.  Dutasteride: a review of its use in the management of prostate disorders.

Authors:  Susan J Keam; Lesley J Scott
Journal:  Drugs       Date:  2008       Impact factor: 9.546

8.  Transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement: a quality and meta-analysis.

Authors:  Seung Wook Lee; Jong Bo Choi; Kyu-Sung Lee; Tae-Hyoung Kim; Hwancheol Son; Tae Young Jung; Seung-June Oh; Hee Jong Jeong; Jae Hyun Bae; Young-Suk Lee; Joon Chul Kim
Journal:  Int Neurourol J       Date:  2013-06-30       Impact factor: 2.835

9.  Clinical effects of discontinuing 5-alpha reductase inhibitor in patients with benign prostatic hyperplasia.

Authors:  Won Kim; Jae Hung Jung; Tae Wook Kang; Jae Mann Song; Hyun Chul Chung
Journal:  Korean J Urol       Date:  2014-01-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.